Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg Yothers

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Statistics in Biosciences|January 10, 2022
A Statistical Method for Association Analysis of Cell Type CompositionsLicai Huang, Paul Little, Jeroen R Huyghe, et al.
Journal of the National Cancer Institute|October 15, 2011
Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trialsGreg Yothers, Daniel J Sargent, Norman Wolmark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
Benefits and adverse events in younger versus older patients receiving adjuvant chemotherapy for colon cancer: findings from the Adjuvant Colon Cancer Endpoints data setJoleen Hubbard, David M Thomas, Greg Yothers, et al.
Diseases of the Colon and Rectum|July 22, 2020
Assessing the Quality of Rectal Cancer Pathology Reports in National Surgical Adjuvant Breast and Bowel Project Protocol R-04/NRG OncologyShonan Sho, Greg Yothers, Linda H Colangelo, et al.
Cancer|January 12, 2013
Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapyFrank A Sinicrope, Nathan R Foster, Greg Yothers, et al.
Clinical Colorectal Cancer|March 29, 2021
Benefit of Oxaliplatin in Stage III Colon Cancer According to IDEA Risk Groups: Findings from the ACCENT Database of 4934 PatientsOfer Margalit, Ben Boursi, Manel Rakez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) DatabaseManish A Shah, Lindsay A Renfro, Carmen J Allegra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Conditional survival and the choice of conditioning set for patients with colon cancer: an analysis of NSABP trials C-03 through C-07Beth A Zamboni, Greg Yothers, Mehee Choi, et al.
NPJ Breast Cancer|November 19, 2022
Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30N Lynn Henry, Sungjin Kim, Ron D Hays, et al.
Cancer|June 24, 2022
Health-related quality of life outcomes after neoadjuvant chemoradiotherapy for rectal cancer in NRG Oncology/NSABP R-04Patricia A Ganz, Ron D Hays, Karen L Spritzer, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Statistics in Biosciences|January 10, 2022
A Statistical Method for Association Analysis of Cell Type CompositionsLicai Huang, Paul Little, Jeroen R Huyghe, et al.
Journal of the National Cancer Institute|October 15, 2011
Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trialsGreg Yothers, Daniel J Sargent, Norman Wolmark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
Benefits and adverse events in younger versus older patients receiving adjuvant chemotherapy for colon cancer: findings from the Adjuvant Colon Cancer Endpoints data setJoleen Hubbard, David M Thomas, Greg Yothers, et al.
Diseases of the Colon and Rectum|July 22, 2020
Assessing the Quality of Rectal Cancer Pathology Reports in National Surgical Adjuvant Breast and Bowel Project Protocol R-04/NRG OncologyShonan Sho, Greg Yothers, Linda H Colangelo, et al.
Cancer|January 12, 2013
Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapyFrank A Sinicrope, Nathan R Foster, Greg Yothers, et al.
Clinical Colorectal Cancer|March 29, 2021
Benefit of Oxaliplatin in Stage III Colon Cancer According to IDEA Risk Groups: Findings from the ACCENT Database of 4934 PatientsOfer Margalit, Ben Boursi, Manel Rakez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) DatabaseManish A Shah, Lindsay A Renfro, Carmen J Allegra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Conditional survival and the choice of conditioning set for patients with colon cancer: an analysis of NSABP trials C-03 through C-07Beth A Zamboni, Greg Yothers, Mehee Choi, et al.
NPJ Breast Cancer|November 19, 2022
Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30N Lynn Henry, Sungjin Kim, Ron D Hays, et al.
Cancer|June 24, 2022
Health-related quality of life outcomes after neoadjuvant chemoradiotherapy for rectal cancer in NRG Oncology/NSABP R-04Patricia A Ganz, Ron D Hays, Karen L Spritzer, et al.
Pageof 12